Skip to main content
Log in

Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neuron systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PEA :

beta-phenylethylamine

DA :

dopamine

DOPAC :

dihydroxyphenylacetic acid

HVA :

homovanillic acid

HPLC-ECD :

high performance liquid chromatography with electrochemical detection

References

  • Bailey BA, Philips SR, Boulton AA (1987) In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudatus nucleus by phenylethylamine. Neurochem Res 12:173–178

    Article  PubMed  Google Scholar 

  • Borison RL, Diamond BI (1978) A new animal model for schizophrenia: interaction with adrenergic mechanisms. Biol Psychiatry 13:217–225

    PubMed  Google Scholar 

  • Borison RL, Havdala HS, Diamond BI (1977) Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia? Life Sci 21:117–122

    Article  PubMed  Google Scholar 

  • Braestrup C, Randrup A (1978) Stereotyped behavior in rats induced by phenylethylamine, dependence on dopamine and noradrenaline, and possible relation to psychosis? In: Mosnaim AD, Wolf ME (eds) Non-catecholic phenylethylamine. Decker, New York, pp 245–269

    Google Scholar 

  • Dourish CT (1981) Behavioral effects of acute and chronic β-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine. Neuropharmacology 20:1067–1072

    Article  PubMed  Google Scholar 

  • Durden D, Philips SR (1980) Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34:1725–1732

    PubMed  Google Scholar 

  • Gianutsos G, Chute S (1986) Pharmacological changes induced by repeated exposure to phenylethylamine. Pharmacol Biochem 25:129–134

    Article  Google Scholar 

  • Greenshow AJ, Dourish CT (1984) Differential aversive stimulus properties of β-phenylethylamine andd-amphetamine. Psychopharmacology 82:189–193

    Article  PubMed  Google Scholar 

  • Hirabayashi M, Alam MR (1981) Enhancing effect of metham phetamine on ambulatory activity produced by repeated administration in mice. Pharmacol Biochem Behav 15:925–932

    Article  PubMed  Google Scholar 

  • Ishibashi K, Matsumoto T, Hirano M, Hirano H, Nakamura K, Nakahara T, Uchimura H (1986) β-Phenylethylamine (PEA) induced behavioral sensitization and changes in monoamine metabolism in discrete rat brain regions. Neurochem Res 11:1799–1800

    Google Scholar 

  • Jeste DV, Kleinman JF, Potkin SG, Luchins DJ, Weinberger DR (1982) Ex Uno Multi: subtyping the schizophrenic syndrome. Biol Psychiatry 17:199–222

    PubMed  Google Scholar 

  • Kokkinidis L, Anisman H (1980) Amphetamine models of paranoid schizophrenia: an overview and elaboration of animal experimentation. Psychol Bull 88:551–579

    Article  PubMed  Google Scholar 

  • König JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain. Williams and Wilkins, Baltimore

    Google Scholar 

  • Kuroki T, Matsumoto T, Hirano M, Kagoshima H, Yao H, Uchimura H, Nakamura K, Nakahara T (1987) Long-lasting effects of systemically administered caerulein on monoaminergic neuronal pathways in rat brain. Neuropeptides 9:169–176

    Article  PubMed  Google Scholar 

  • Kuroki T, Tsutsumi T, Hirano M, Matsumoto T, Uchimura H, Shiraishi A, Nakahara T (1988) Involvement of central dopaminergic neuron systems in beta-phenylethylamine (PEA)-induced behavioral sensitization of the rat. Psychopharmacology 96:S371

    Google Scholar 

  • Murphy DL, Belmaker RT, Carpenter WT, Wyatt RJ (1977) Monoamine oxidase in chronic schizophrenia: studies of hormonal and their factors affecting enzyme activity. Br J Psychiatry 130:151–158

    PubMed  Google Scholar 

  • Nielsen JA, Chapin DS, Moore KE (1983) Differential effects ofd-amphetamine, β-phenylethylamine, cocaine and methylphenidate on the rat of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates of rat. Life Sci 33:1899–1907

    Article  PubMed  Google Scholar 

  • Nishikawa T, Mataga N, Takashima M, Toru M (1983) Behavioral sensitization and relative hyper-responsiveness of striatal and limbic dopaminergic neurons after repeated amphetamine treatment. Eur J Pharmacol 88:195–203

    Article  PubMed  Google Scholar 

  • Paulos M, Tessel RE (1982) Excretion ofβ-phenylethylamine is elevated in human after profound stress. Science 215:1127–1129

    PubMed  Google Scholar 

  • Philips SR, Robson AM (1983) In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine. Neuropharmacology 22:1297–1301

    Article  PubMed  Google Scholar 

  • Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Philips I, Wyatt RJ (1979) Phenylethylamine in paranoid chronic schizophrenia. Science 206:470–471

    PubMed  Google Scholar 

  • Robinson TE, Becker JB (1982) Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from stratal tissue in vitro. Eur J Pharmacol 85:253–254

    Article  PubMed  Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198

    Article  Google Scholar 

  • Robinson TE, Jurson PJ, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211–222

    Article  PubMed  Google Scholar 

  • Shiraishi A, Hirano M, Matsumoto T, Kagoshima H, Kuroki T, Uchimura H, Nakahara T, Ishibashi K (1987) Stereotyped behaviors and the reverse tolerance phenomenon induced by chronicβ-phenylethylamine administration in the rats. Jpn J Psychopharmacol 7:83–84

    Google Scholar 

  • Szymanski HV, Naylor EW, Karoum F (1987) Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients. Biol Psychiatry 22:194–198

    Article  PubMed  Google Scholar 

  • Ungerstedt U, Herrera-Marshitz M, Jungenelius U, Stahle L, Tossman U, Zetterstrom T (1982) Dopamine synaptic mechanisms reflected in studies containing behavioral recordings and brain dialysis. Adv Dopamine Res 37:219–231

    Google Scholar 

  • Wallach MB (1974) Drug-induced stereotyped behaviors: similarities and differences. In: Usdin E (ed) Neuropsychopharmacology of monoamines and their regulatory enzymes. Raven Press, New York, pp 241–260

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuroki, T., Tsutsumi, T., Hirano, M. et al. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat. Psychopharmacology 102, 5–10 (1990). https://doi.org/10.1007/BF02245736

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245736

Key words

Navigation